UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                    Washington, D.C.  20549
                           Form 10-Q


(MARK ONE)  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D)
X           OF THE SECURITIES EXCHANGE ACT OF 1934 
-                                                       

For the quarterly period ended December 31, 1995  
                               -----------------

                              OR 

            TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)
-           OF THE SECURITIES EXCHANGE  ACT OF 1934    
                                                       
For the transition period from        to            

                                                    
Commission file number   1-07151
                         -------

                          THE CLOROX COMPANY
-----------------------------------------------------------------
      (Exact name of registrant as specified in its charter) 

                                                       
     DELAWARE                                         31-0595760
-----------------------------------------------------------------
(State or other jurisdiction of                 (I.R.S. Employer
 incorporation or organization)                Identification No.)
                                                       

1221 Broadway - Oakland, California                  94612 - 1888
-----------------------------------------------------------------
(Address of principal executive offices

Registrant's telephone number (including area code) (510) 271-7000
                                                    --------------

-----------------------------------------------------------------
(Former name, former address and former fiscal year, if changed
 since last report)

Indicate by check mark whether the registrant (1) has filed all
report required to be filed by Section 13 or 15(d) of the 
Securities Exchange Act of 1934 during the preceding 12 months 
(or for such shorter period that the registrant was required to 
file such reports), and (2) has been subject to such filing 
requirements for the past 90 days.                    

          Yes         X           No                   
                    -----            -----
             
As of December 31, 1995 there were 51,910,594 shares outstanding of
the registrant's common stock  (par value -  $1.00),  the 
registrant's only outstanding class of stock.

------------------------------------------------------------------
                                                        
                                                  Total  pages 10
                                                                1
                                                                -

<PAGE>

                        THE CLOROX COMPANY

                         
PART 1.  Financial Information                       Page No. 
         ---------------------                       --------

         Item 1.  Financial Statements           
                         
                  Condensed Statements of 
                  Consolidated Earnings                
                    Three and Six Months Ended 
                    December 31, 1995 and 1994           3 
                          
                            
                  Condensed Consolidated Balance
                  Sheets           
                    December 31, 1995 and June 30,
                    1995                                 4 
                          
                           
                  Condensed Statements of Consolidated
                  Cash Flows            
                    Six Months Ended December 31, 1995
                    and 1994                             5 
                          
                         
                  Notes to Condensed Consolidated
                  Financial Statements                   6 
                         
                         
     Item 2.  Management's Discussion and Analysis of 
              Results of Operations and Financial 
              Condition                                  7-9 







                                                          2
                                                          -


<PAGE>
<TABLE>
<CAPTION>


                             PART I - FINANCIAL INFORMATION
                              Item 1. Financial Statements
                           The Clorox Company and Subsidiaries
                        Condensed Statements of Consolidated Earnings
                        ---------------------------------------------
                         (In thousands, except per share amounts)


                                        Three Months Ended                                   Six Months Ended
                              --------------------------------                     --------------------------------
                              12/31/95                12/31/94                     12/31/95                12/31/94
                              --------                --------                     --------                --------
<S>                           <C>                     <C>                          <C>                     <C>

Net Sales                     $ 466,789               $ 414,454                    $ 985,275               $ 890,821 
                                                                                
Costs and Expenses                                                                               
  Cost of products sold         213,171                 183,963                      444,504                 394,097 
                                                                         


  Selling, delivery and
  administration                102,378                  91,885                      201,034                 181,356 
                                                                                
  Advertising                    66,628                  68,007                      139,110                 138,974 
                                                                                
  Research and development       11,205                  10,817                       21,407                  20,917 
                                                                                
  Interest expense                7,588                   5,163                       15,360                  10,089 
                                                                                
  Other expense (income), net     2,196                  (2,164)                       1,629                  (1,802) 
                                -------                 -------                      -------                 -------
                                              
    Total costs and expenses    403,166                 357,671                      823,044                 743,631 
                                -------                 -------                      -------                 -------
                                                                         
                                                               
Earnings before income taxes     63,623                  56,783                      162,231                 147,190 
                                                                                
Income Taxes                     25,712                  22,688                       65,541                  59,914 
                                -------                 -------                      -------                 -------
                 
Net Earnings                 $   37,911              $   34,095                   $   96,690              $   87,276 
                             ==========              ==========                   ==========              ==========
                                                               
                                                                
Earnings per Common Share    $     0.73              $     0.64                   $     1.85              $     1.64 
                                                                               
Dividends per Share          $     0.53              $     0.48                   $     1.06              $     0.96 
                                                                             
Weighted Average Shares
Outstanding                      52,089                  53,274                       52,222                  53,341 
                                                                              
                                                                           

                                                                          
See Notes to Condensed Consolidated Financial Statements.


                                                                               3
                                                                               -
</TABLE>


<PAGE>
<TABLE>
<CAPTION>


                            PART I - FINANCIAL INFORMATION (Continued)
                                   Item 1. Financial Statements
                              The Clorox Company and Subsidiaries
                              Condensed Consolidated Balance Sheets
                              -------------------------------------
                                        (In thousands)


                                                                   12/31/95                6/30/95
                                                               ----------------        ---------------
<S>                                                            <C>                     <C>

ASSETS
------
                                              
     Current Assets                                          
          Cash and short-term investments                      $      105,866          $      137,330 
          Accounts receivable, less allowance                         220,371                 311,868 
          Inventories                                                 157,524                 121,095 
          Deferred income taxes                                        11,575                  11,495 
          Prepaid expenses                                             16,219                  18,543 
                                                               ----------------        ---------------
               Total current assets                                   511,555                 600,331 
                                                  
     Property, Plant and Equipment - Net                              533,208                 524,972 
                                                  
     Brands, Trademarks, Patents and Other Intangibles                599,880                 592,792 
                                                  
     Investments in Affiliates                                         94,225                  96,385 
                                                  
     Other Assets                                                     120,355                  92,192 
                                                               ----------------        ---------------
     Total                                                     $    1,859,223          $    1,906,672 
                                                               ================        ===============
                                                  

LIABILITIES AND STOCKHOLDERS' EQUITY                                                   
------------------------------------
     Current Liabilities                                              
          Accounts payable                                     $       89,462          $      122,763 
          Accrued liabilities                                         187,754                 234,595 
          Income taxes payable                                         11,991                   6,283 
          Commercial paper and notes payable                          168,526                 115,303 
          Current maturities of long-term debt                            395                     379 
                                                               ----------------        ---------------
               Total current liabilities                              458,128                 479,323 
                                                  
     Long-term Debt                                                   249,487                 253,079 
                                               
     Other Obligations                                                 80,987                  85,129 
                                                  
     Deferred Income Taxes                                            136,957                 145,228 
                                                
     Put Option Obligations                                            17,259                    - 
                                              
     Stockholders' Equity                                             
          Common Stock                                                 55,422                  55,422 
          Additional paid-in capital                                  109,068                 108,347 
          Retained earnings                                         1,011,177                 971,380 
          Treasury shares, at cost                                   (228,813)               (168,217) 
          Cumulative translation adjustments and other                (30,449)                (23,019) 
                                                               ----------------        ---------------
               Stockholders' Equity                                   916,405                 943,913 
                                                               ----------------        ---------------
                                               
     Total                                                     $    1,859,223          $    1,906,672 
                                                               ================        ===============
                                             
See Notes to Condensed Consolidated Financial Statements.                                              
                                                                               

                                                                              4
                                                                              -

</TABLE>









<PAGE>
<TABLE>
<CAPTION>



                          PART I - FINANCIAL INFORMATION (Continued)
                              Item 1.  Financial Statements
                            The Clorox Company and Subsidiaries
                        Condensed Statements of Consolidated Cash Flows
                        -----------------------------------------------
                                        (In thousands)


                                                                                      Six  Months Ended 
                                                                             --------------------------------------
                                                                                12/31/95                12/31/94   
                                                                             -------------           --------------
<S>                                                                          <C>                     <C>
Operations:                                              
     Earnings from continuing operations                                     $      96,690           $      87,276 
     Adjustments to reconcile to net cash provided by operating activities:                                            
          Depreciation and amortization                                             55,669                  51,445 
          Deferred income taxes                                                      3,300                   5,400 
          Other                                                                     12,532                  10,230 
          Effects of changes in:                                       
               Accounts  receivable                                                 91,497                  71,938 
               Inventories                                                         (33,505)                (50,089) 
               Prepaid expenses                                                      2,243                   2,460 
               Accounts payable                                                    (33,385)                (19,886) 
               Accrued liabilities                                                 (44,049)                (42,100) 
               Income taxes payable                                                 (5,863)                 (4,078)
                                                                             -------------           --------------

               Net cash provided by  operations                                    145,129                 112,596 
                                                

Investing Activities:                                                 
     Property, plant and equipment                                                 (30,658)                (28,803) 
     Disposal of property, plant and equipment                                         770                     550 
     Businesses purchased                                                          (61,665)                (24,165) 
     Other                                                                         (22,168)                (18,083) 
                                                                             -------------           --------------
               Net cash used for investment                                       (113,721)                (70,501) 
                                                

Financing Activities:                                              
     Short-term borrowings                                                                                   6,031 
     Long-term debt and other obligations repayments                               (12,696)                   (207) 
     Commercial paper, net                                                          53,223                  44,038 
     Cash dividends                                                                (55,537)                (51,298) 
     Treasury stock purchased                                                      (50,150)                (26,682) 
     Employee stock plans                                                            2,288                   4,458 
                                                                             -------------           --------------
               Net cash used for financing                                         (62,872)                (23,660) 
                                                                             -------------           --------------

(Decrease) Increase in Cash and Short-Term Investments                             (31,464)                 18,435 
Cash and Short-Term Investments:                                                
     Beginning of period                                                           137,330                 115,922 
                                                                             -------------           --------------
                                                
     End of period                                                           $     105,866           $     134,357 
                                                                             =============           ==============
                                             
                                             
See Notes to Condensed Consolidated Financial Statements.
                                 
                                   
                                                                                           5
                                                                                           -
</TABLE>

<PAGE>

          PART I - FINANCIAL INFORMATION (Continued)
              Item 1.  Financial Statements
            The Clorox Company and Subsidiaries
        Notes to Condensed Consolidated Financial Statements
        ----------------------------------------------------


(1)  The summarized financial information for the three and six 
     months ended December 31, 1995 and 1994 has not been audited
     but, in the opinion of management, all adjustments (consisting
     only of normal recurring accruals) necessary for a fair 
     presentation of the results of operations, financial position, 
     and cash flows of The Clorox Company and subsidiaries (the 
     Company) have been made.  The results of the three and six 
     months ended December 31, 1995 and 1994 should not be 
     considered as necessarily indicative of the results for the 
     entire year.


(2)  Inventories at December 31, 1995 and at June 30, 1995 consisted
     of (in thousands):
                                                                 
                                 12/31/95                6/30/95
                                 --------                -------
                     
                                                                 
     Finished goods and work
     in process                  $ 99,147                $ 71,102
     Raw materials and
     supplies                      58,377                  49,993
                                 --------                --------
          Total                  $157,524                $121,095
                                 ========                ========
     

(3)  Stock Repurchases

     The Company's Board of Directors in July 1995, authorized a 
     $100,000,000 share repurchase program which is planned for 
     completion during fiscal year 1996.  The shares will be 
     purchased on the open market.  Shares reacquired will be 
     held as treasury shares and are available for reissuance 
     for corporate uses.  Through December 31, 1995, 697,000 
     shares had been repurchased at a cost of $50,150,000.


(4)  Acquisitions for the six months ended December 31, 1995 of 
     $61,665,000 were funded from cash provided from operations 
     and included the Black Flag line of insecticides, the 
     acquisition of the remaining minority interest of our business 
     in Argentina, and other business interests in Mexico.  These 
     acquisitions were accounted for as purchases.


(5)  Put Option Obligations

     The Company sold 240,000 put options and purchased 240,000 
     call options during the second quarter of fiscal 1996 
     with various strike prices (average of $71.91 per share) 
     that expire at various times through September 30, 2005.  
     Upon exercise, each put option obligates the Company to 
     purchase one share of its common stock at the strike price 
     and each call option allows the Company to purchase one 
     share of its common stock at the strike price.  The 
     aggregate exercise price of $17,259,000 has been classified 
     as put option obligations with a corresponding increase in 
     treasury stock at December 31, 1995.

                                                              6
                                                              -

<PAGE>


              PART I - FINANCIAL INFORMATION (Continued)
           Item 2.  Management's Discussion and Analysis of
            Results of Operations and Financial Condition
            ---------------------------------------------

                     Results of Operations
                     ---------------------

        Comparison of the Three Months Ended December 31, 1995
        ------------------------------------------------------
           with the Three Months Ended December 31, 1994
           ---------------------------------------------


Earnings per share increased 14 percent to $.73 from $.64, and net 
earnings increased 11 percent to $37,911,000 from $34,095,000 a 
year ago principally due to a 13 percent increase in net sales 
driven by a 13 percent increase in volume.  Record shipments were 
recorded for our home cleaning business unit which includes 
Formula 409, Soft Scrub, Pine-Sol and Clorox toilet bowl cleaners.
This business unit achieved its twelfth consecutive quarterly 
increase in shipments.  Combat insecticides and Kingsford charcoal 
shipments were also up strongly.  Brita water filtration systems 
shipped record quarterly volumes reflecting strong growth in all 
trade channels and the acquisition in January 1995 of the Brita 
business in Canada.  Our international business growth during the 
quarter was principally due to volume from businesses acquired in 
fiscal 1995. 

Cost of products sold as a percentage of net sales was 45.7 and 
44.4 percent in the current and year ago quarters, respectively.  
Gross margins are anticipated to remain at approximately 55 percent
for the remainder of the fiscal year.

Selling, delivery, and administration expense increased 11 percent 
over the year ago period principally due to continued investment 
in international infrastructure, and costs implementing our 
customer interface project.

Advertising expense decreased 2 percent over the year ago 
period principally due to reductions in sales promotion 
activities (e.g. couponing).  However, media spending has 
increased versus a year ago and we expect it to increase for 
the full year in line with sales.

Interest expense increased $2,425,000 over the year ago period 
due to higher levels and rates on commercial paper, and 
additional indebtedness related to the Brita Canada acquisition 
of January 1995.

                                                         7
                                                         -

<PAGE>


            PART I - FINANCIAL INFORMATION (Continued)
           Item 2.  Management's Discussion and Analysis of
            Results of Operations and Financial Condition
            ---------------------------------------------

                     Results of Operations
                     ---------------------

        Comparison of the Six Months Ended December 31, 1995
        ----------------------------------------------------
             with the Six Months Ended December 31, 1994
             -------------------------------------------


Earnings per share increased 13 percent to $1.85 from $1.64, and
net earnings increased 11 percent to $96,690,000 from 
$87,276,000 a year ago principally due to a 11 percent 
increased in net sales driven by a 10 percent increase in 
volume.  Record shipments were recorded in both the first 
and second quarters for our home cleaning business unit 
which includes Formula 409, Soft Scrub, Pine-Sol and Clorox 
toilet bowl cleaners.  Combat insecticides and Kingsford 
charcoal shipments were both up in volume versus the year ago 
period.  Brita water filtration systems shipped record volumes 
that reflect continued strong growth in all trade channels and 
the acquisition in January 1995 of the Brita business in Canada.  
International volume growth was principally due to volume from 
businesses acquired in fiscal 1995. 

Cost of products sold was 45.1 and 44.2 percent in the current 
and year ago periods respectively.  Gross margins are expected 
to remain at approximately 55 percent for the remiander of 
the fiscal year.

Selling, delivery and administration expense increased 11 
percent over the year ago period principally due to continued 
investment in international infrastructure, and costs 
implementing our customer interface project.

Advertising expense was about even with a year ago.  Included 
in advertising expense is a shift from sales promotion to 
media spending which improves the overall efficiency of 
the advertising effort. 

Interest expense increased $5,271,000 over a year ago due to 
higher levels and rates on commercial paper, and additional 
indebtedness related to the Brita Canada acquisition of 
January 1995.

                                                            8
                                                            -

<PAGE>



               PART I - FINANCIAL INFORMATION (Continued)
            Item 2.  Management's Discussion and Analysis of
              Results of Operations and Financial Condition
              ---------------------------------------------

                   Liquidity and Capital Resources
                   -------------------------------


The Company's financial position and liquidity remain strong due 
to cash provided by operations which increased $32,533,000 over 
the year ago period, principally due to the liquidation of 
June 30, 1995 receivables including those with seasonal dating 
terms for payment  this period.  Decreases in accounts receivable 
and accounts payable, and increases in inventory balances from 
June 30, 1995 reflect normal seasonal variation, principally 
due to the charcoal and insecticides businesses.  We expect 
inventories to increase during the next fiscal quarter to 
support the seasonal charcoal and insecticides businesses.

In July 1995, the Board of Directors approved a $100,000,000 
share repurchase program which is planned for completion 
during this fiscal year, subject to market conditions and 
business opportunities which may arise.  Through the six 
month period ended December 31, 1995, 697,000 shares at a cost 
of $50,150,000 were reacquired, of which 418,400 shares at a 
cost of $31,331,000 were reacquired during the second quarter.  
The Company also sold 240,000 put options on the Company's 
stock during the second quarter as a hedge of certain future 
stock option exercises.  The options sold were unexpired and 
unexercised at December 31, 1995.

The Company has approved the use of interest rate derivative 
instruments such as interest rate swaps in order to manage 
the impact of interest rate movements on interest expense.  
These instruments have the effect of converting fixed rate 
interest to floating, or floating to fixed.  The conditions 
under which derivatives can be used are set forth in a Company 
Policy Statement and include a restriction on the amount of 
such activity to a designated portion of existing debt, a 
limit on the term of any derivative transaction, and a 
specific prohibition on the use of any leveraged derivatives.

Management believes the Company has access to additional 
capital through existing lines of credit and from public 
and private sources should the need arise.



                                                          9
                                                          -

<PAGE>



                            S I G N A T U R E


Pursuant to the requirements of the Securities Exchange Act 
of 1934, the registrant has duly caused this report to be 
signed on its behalf by the undersigned thereunto duly 
authorized.


                                   THE CLOROX COMPANY
                                   (Registrant)




DATE                             BY  /S/ HENRY J. SALVO, JR.
     -----------------               -----------------------
                                        Henry J. Salvo, Jr.
                                        Vice-President - 
                                        Controller




                                                     10
                                                     --